NCT02060084View on ClinicalTrials.gov

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Disorder of Stomach Function and Feeding Problems in NewbornFeeding and Eating Disorders of Childhood
Interventions
DRUG

a control group

the same dose of luke warm water

DRUG

a probiotic-supplemented group

was orally administered starting from day 2 after birth, at a dose of 0.5g (the numbers of Long Bifidobacterium, Lactobacillus acidophilus and Enterococcus faecalis in live\>0.5\*107CFU), twice per day, for 2 weeks

Trial Locations (1)

215300

Kunshan First Hospital, Kunshan

All Listed Sponsors
lead

Wang Hua

INDUSTRY

NCT02060084 - Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm | Biotech Hunter | Biotech Hunter